Effects of cyclohexanonic long-chain fatty alcohol, tCFA15 on amino acids in diabetic rat brain: A preliminary study

Neurochemical Research

Volumn 33, Issue 7, 2008, Pages 1189-1195

  Shinbori, Chiko ^a   Shirayama, Yukihiko ^a,b   Mitani, Hideaki ^a   Saito, Motoaki ^a   Satoh, Keisuke ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amino acids; Brain; Cyclohexanonic long chain fatty alcohol; Diabetes; Rat; Streptozotocin

Indexed keywords

3 (15 HYDROXYPENTADECYL) 2,4,4 TRIMETHYL 2 CYCLOHEXEN 1 ONE; 4 AMINOBUTYRIC ACID; ALANINE; AMINO ACID; ARGININE; ASPARTIC ACID; CYCLOHEXANE; FATTY ALCOHOL; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HEXACOSANOL; SERINE; TAURINE; THREONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STRIATE CORTEX;

AMINO ACIDS; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANONES; DIABETES MELLITUS, EXPERIMENTAL; FATTY ALCOHOLS; INSULIN; MALE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 44549086181     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9611-2     Document Type: Article

References (61)

1. Berlin I, Bisserbe JC, Eiber R et al (1997) Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diabetes Care 20:176-178
2. Lustman PJ (1998) Anxiety disorders in adults with diabetes mellitus. Psychiatr Clin North Am 11:419-432
3. Petrak F, Hardt J, Wittchen HU et al (2003) Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetes. Diabetes Metab Res Rev 19:216-222
4. Peyrot M, Rubin RR (1997) Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 20:585-590
5. Lustman PJ, Anderson RJ, Freedland KE et al (2000) Depression and poor glycemic control: a meta-analysis review of the literature. Diabetes Care 23:934-942
6. de Groot M, Anderson RJ, Freedland KE et al (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619-630
7. Anderson RJ, Freedlank KE, Clouse RE et al (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069-1078
8. Reaven GM, Thompson LW, Nahum D et al (1990) Relationship between heperglycemia and cognitive function in older NIDDM patients. Diabetes Care 13:16-21
9. Helkala EL, Niskanen L, Viinamaki H et al (1995) Short-term and long-term memory in elderly patients with NIDDM. Diabetes Care 18:681-685
10. Brands AM, Biessels GJ, de Haan EH et al (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726-735
11. Biessels GJ, Kamal A, Urban IJ et al (1998) Water maze learning and hipocampal synaptic plasticity in streptozocin-diabetic rats: effects of insulin treatment. Brain Res 800:125-135
12. Hilakivi-Clarke LA, Wozniak KM et al (1990) Behavior of streptozocine-diabetic mice in tests of exploration, locomotion, anxiety, depression, and aggression. Physiol Behav 48:429-433
13. Massol J, Martin P, Belon JP et al (1989) Helpless behavior (escape deficits) in streptozotocin-diabetic rats: resistance to antidepressant drugs. Psychoneuroendocrinology 14:145-153
14. Kamei J, Miyata S, Morita K et al (2003) Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice. Pharmacol Biochem Behav 75:247-254
15. Scribner KA, Walker CD, Cascio CS et al (1991) Chronic streptozotocin diabetes in rats facilitates the acute stress response without altering pituitary or adrenal responsiveness to secretagogues. Endocrinology 129:99-108
16. Magnorinos AM, McEwen BS (2000) Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc Natl Acad Sci USA 97:11056-11061
17. 1A receptor in the mouse tail suspension test. Neuropsychopharmacology 29:461-469
18. Kamei J, Saitoh A, Iwamoto Y, Funada M, Suzuki T, Misawa M, Nagase H, Kasuya Y (1994) Effects of diabetes on spontaneous locomotor activity in mice. Neurosci Lett 178:69-72
19. Yamaoto T, Misumi Y, Yamasaki S et al (2004) Diabetic mellitus decreases hippocampal release of neurotransmitters: an in vivo microdialysis study of awake, freely moving rats. Diabetes Nutr Metab 17:128-136
20. Miyata S, Yamada N, Hirano S et al (2007) Diabetes attenuates psychological stress-elicited 5-HT secretion in the prefrontal cortex but not in the amygdala of mice. Brain Res 1147:233-239
21. 2A receptors in the rat brain. Neuropsychopharmacology 19:83-190
22. Gomez R, Vargas CR, Wajner M et al (2003) Lower in vivo brain extracellular GABA concentration in diabetic rats during forced swimming. Brain Res 968:281-284
23. Guyot LL, Diaz FG, O'Regan MH et al (2001) The effect of streptozotocin-induced diabetes on the release of excitotoxic and other amino acids from the ischemic rat cerebral cortex. Neurosurgery 48:385-390
24. Borg J, Toazara J, Heitter H et al (1987) Neurotrophic effect of naturally occurring long-chain fatty alcohols on cultured CNS neurons. FEBS Lett 213:406-410
25. Borg J, Kesslak PJ, Cotman CW (1990) Peripheral administration of a long-chain fatty alcohol promotes septal cholinergic neurons survival after fimbria-fornix transection. Brain Res 518:295-298
26. Luu B, de Aguilar JLG, Junges CG (2000) Cyclohexenonic long-chain fatty alcohols as neuronal growth stimulators. Molecules 5:1439-1460
27. Suzuki H, Yamada M, Saito M et al (2006a) Cognitive enhancing effect of tCFA15 in a cerebral ischemia model in rats. Jpn Pharmacol Ther 34:639-645
28. Hanada T, Saito M, Kanzaki S (2006) Treatment with cyclohexenonic long-chain fatty alcohol reverses diabetes-induced tracheal dysfunction in the rat. Pharmacology 78:51-60
29. Kinoshita Y, Saito M, Satoh I et al (2006) General administration of cyclohexenonic long-chain fatty alcohol ameliorates hyperreactivity of STZ-induced diabetic rat aorta. Life Sci 78:1508-1514
30. Satoh I, Saito M, Kinoshita Y et al (2005) Effects of cyclohexenonic long-chain fatty alcohol on diabetic rat trachea. Life Sci 77:2030-2039
31. Saito M, Kinoshita Y, Satoh I et al (2006) N-hexacosanol ameliorates streptozotocin induced diabetic nephropathy. Eur J Pharmacol 544:132-137
32. Shinbori C, Saito M, Kinoshita Y et al (2006) N-hexacosanol reverses diabetic induced muscarinic hypercontractility of ileum in the rat. Eur J Pharmacol 545:177-184
33. Suzuki H, Saito M, Kinoshita Y et al (2006b) Preventive effect of cyclohexenonic long-chain fatty alcohol on diabetic neuropathy in the rat bladder. Can J Physiol Pharmacol 84:195-20
34. Saito M, Kinoshita Y, Satoh I et al (2007) Ability of cyclohexenonic long-chain fatty alcohol to reverse diabetes-induced cystopathy in the rat. Eur Urol 51:479-488
35. D'Andrea G, Cananzi AR, Joseph R et al (1991) Platelet glycine, glutamate and aspartate in primary headache. Cephalgia 11:197-200
36. Morikawa A, Hamase K, Inoue T et al (2001) Determination of free d-aspartate acid, d-serine and d-alanine in the brain of mutant mice lacking d-amino acid oxidase activity. J Chromatography B 757:119-125
37. Bremner E, Kond D, Haber A et al (2000) Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801. J Neurochem 94:1594-1603
38. Galanopoulos E, Lellos V, Papadakis M et al (1988) Effects of fasting and diabetes on some enzymes and transport of glutamate in cortex slices or synaptosomes from rat brain. Neurochem Res 13:243-248
39. Duarte AI, Santos MS, Seica R et al (2004) Oxidative stress affects synaptosomal gamma-aminobutyric acid and glutamate transport in diabetic rats: the role of insulin. Diabetes 53:2110-2116
40. Altamura CA, Mauri MC, Ferrara A et al (1993) Plasma and platelet excitatory amino acids in psychiatry disorders. Am J Psychiatry 150:1731-1733
41. Mauri MC, Ferrara A, Boscati L et al (1998) Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology 37:124-129
42. Mitani H, Shirayama Y, Yamada T et al (2006) Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuro-Psychopharmac Biol Psychiatry 30:1155-1158
43. Sanacora G, Gueorguieva R, Epperson CN et al (2004) Subtype-specific alterations of γ-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61:705-713
44. Hasler G, van der Veen JW, Tumonis T et al (2007) Reduced prefrontal glutamate/glutamine and γ-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64:193-200
45. Ramonet D, Rodriguez MJ, Fredriksson K et al (2004) In vivo neuroprotective adaptation of the glutamate/glutamine cycle to neuronal death. Hippocampus 14:586-594
46. 13NMR. NMR Biomed 16:440-449
47. Sakurai S, Ishii S, Umino A et al (2004) Effects of psychotomimetic and antipsychotic agents on neocortical and striatal concentrations of various amino acids in the rat. J Neurochem 90:1378-1388
48. Maes M, Verkerk R, Vandoolaeghe E et al (1998) Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiatr Scand 97:302-308
49. B receptors in rat hippocampal CA1 area. Brain Res 864:298-307
50. Mori M, Gahwiler BH, Gerber U (2002) β-Alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. J Physiol 539:191-200
51. Altamura CA, Maes M, Dai J et al (1995) Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. Eur Neurosychopharmacol 5 Suppl:71-75
52. EI-Missiry MA, Othman AI, Amer MA (2004) l-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus. J Appl Toxicol 24:93-97
53. van London L, Goekoop JG, van Kempen GM et al (1997) Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 17:284-292
54. de Winter RF, van Hemert AM, DeRijk RH et al (2003) Anxious-retarded depression: relation with plasma vasopressin and cortisol. Neuropsychopharmacology 28:140-147
55. Matsuoka T, Sumiyoshi T, Tanaka K et al (2005) NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: therapeutic implications for schizophrenia. Brain Res 1053:131-136
56. Jackson-Guilford J, Leander JD et al (2000) The effects of streptozocine-diabetes on cell proliferation in the rat dentate gyrus. Neurosci Lett 293:91-94
57. Li ZG, Zhang W, Grunberger G, Sima AA (2002) Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 946:221-231
58. Beauquis J, Roig P, Homo-Delarche F et al (2006) Reduced hippocampal neurogenesis and number of hilar neurons in streptozotocin-induced diabetic mice: reversion by antidepressant treatment. Eur J Neurosci 23:1539-1546
59. Martinez-Tellez R, Gomez-Villalobos Mde J, Flores G (2005) Alteration in dendritic morphology and cortical neurons in rats with diabetes mellitus induced by streptozotocin. Brain Res 1048:108-115
60. Kamal A, Biessels GJ, Urban IJ et al (1999) Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and faciliation of long-term depression. Neuroscience 90:737-745
61. Grillo CA, Piroli GG, Wood GE et al (2005) Immunocytochemical analysis of synaptic proteins provided new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience 136:477-486